Displaying 41 - 60 of 1591
FTC Releases Second Interim Staff Report on Prescription Drug Middlemen
FTC Announces Tentative Agenda for January 14 Open Commission Meeting
FTC Announces Refund Claims Process for Consumers Who Bought Deceptively Marketed Golden Sunrise Nutraceutical Products
FTC Statement on Appellate Court Decision Ordering Delisting of Teva Inhaler Patents
FTC Staff Sends Warning Letters to Healthcare Plan Marketers and Lead Generators
Statement of Chair Lina M. Khan In the Matter of Cooperativa de Farmacias Puertoriqueñas
FTC Approves Modification of Cooperativa De Farmacias Puertorriqueñas Final Commission Order
Statement of Commissioner Melissa Holyoak In the Matter of Cooperativa De Farmacias Puertorriqueña
SuperGoodDeals.com, Inc.
The FTC filed a complaint against SuperGoodDeals.com, Inc. and its owner, Kevin J. Lipsitz, alleging that the defendants falsely promised consumers next-day shipping of facemasks and other personal protective equipment (PPE) to deal with the coronavirus pandemic. In addition, the FTC alleged that some of the other merchandise sold through the SuperGoodDeals website were falsely advertised as “authentic” or “certified.”
Kevin Lipsitz, who defrauded consumers by falsely promising “next day” shipping of facemasks and respirators to consumers at the height of the COVID-19 pandemic, will be banned from selling personal protective equipment (PPE) and be required to turn over more than $145,000 to the FTC.
In December 2024, the FTC sent more than $114,000 to consumers who were deceived by “next day shipping” claims on badly needed personal protective equipment (PPE) by online seller SuperGoodDeals.com.
Statement Regarding Union Health’s COPA Application Withdrawal
Mobile Health App Interactive Tool
FTC Sends More Than $1.1 Million in Refunds to Consumers Deceived by Bait-and-Switch Ads for LASIK Vision Correction Procedures
LCA-Vision Inc. d/b/a LasikPlus
In January 2023, the FTC issued an order requiring Ohio-based LCA-Vision, doing business as LasikPlus and Joffe MediCenter, to pay $1.25 million for using deceptive bait-and-switch advertising to trick consumers into believing they could have their vision corrected for less than $300. The order also bans the defendants from making the misrepresentations detailed in the complaint. The Commission approved the final consent order in March 2023. In October 2024, the FTC announced it was returning $1.1 million to defrauded consumers.
FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices
FTC Staff Opposes Proposed Indiana Hospital Merger
Staff Submission to Indiana Health Department Regarding the COPA Application of Union Health and Terre Haute Regional Hospital
Displaying 41 - 60 of 1591